Skip to main content
OpenTrials

Clinical trial condition

Anemia

Explore clinical trials studying Anemia. Study availability and eligibility vary by location and protocol.

809 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

Anemia trial results

Active, not recruiting

A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia

NCT05664737

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • Local Institution - 0011 Haikou, Hainan, China
  • Local Institution - 0012 Kunming, Yunnan, China
  • Local Institution - 0018 Rio, G, Greece
  • Local Institution - 0006 Athens, Greece
View all 31 locations
View Trial Details
Active, not recruiting

Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia

NCT00843882

Conditions
Anemia, Bone Marrow Diseases, Chronic Disease, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Anchorage Oncology Centre Anchorage, Alaska, United States
View all 507 locations
View Trial Details
Active, not recruiting

Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis

NCT07119372

Conditions
Anemia, Chronic Disease, Chronic Kidney Disease, +15 more
Locations
  • Limited Liability Company "Medical Center "NEFROS" Krasnodar, Russia
  • Limited Liability Company Medical Center "NEPHROS" Krasnodar, Russia
  • Limited Liability Company "Nephroline-Sibir" Novosibirsk, Russia
  • State Autonomous Healthcare Institution Orenburg Regional Clinical Center of Surgery and Traumatology Orenburg, Russia
View all 14 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India

NCT05891249

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations
  • Local Institution - 0002 Ahmedabad, Gujarat, India
  • Local Institution - 0001 New Delhi, National Capital Territory of Delhi, India
  • Local Institution - 0007 Kolkata, West Bengal, India
  • Local Institution - 0005 Assam, India
View Trial Details
Active, not recruiting

Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT02048813

Conditions
Anemia, Chronic Disease, Chronic Lymphocytic Leukemia, +16 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 781 locations
View Trial Details
Active, not recruiting

Evaluation of a Comprehensive School Health Programme in Zambia

NCT06560853

Conditions
Anemia, Diarrhea, Hematologic Diseases, +10 more
Locations
  • Chingola District Education Board Chingola, Copperbelt, Zambia
  • Luanshya District Education Board Luanshya, Copperbelt, Zambia
  • Masaiti District Education Board Masaiti, Copperbelt, Zambia
  • Kawambwa District Education Board Kawambwa, Luapula Province, Zambia
View Trial Details
Active, not recruiting

An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions

NCT04717414

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +5 more
Locations
  • Local Institution - 110 Los Angeles, California, United States
  • Local Institution - 135 Orlando, Florida, United States
  • Local Institution - 133 Plantation, Florida, United States
  • Local Institution - 112 Chicago, Illinois, United States
View all 185 locations
View Trial Details
Active, not recruiting

INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders

NCT04455841

Conditions
Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope Orange County Irvine, California, United States
  • Usc Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford Cancer Center Palo Alto, California, United States
View all 34 locations
View Trial Details

Related conditions